ViroPharma, Inc. (NASDAQ:VPHM)
| CAPS Rating |
|
|---|---|
| Open | $30.46 |
| Previous Close | $30.65 |
| Daily Range | $30.16 - $30.88 |
| 52-Week Range | $14.62 - $31.00 |
| Market Cap | $2.32B |
| P/E Ratio | 12.30 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 655,097 |
| Average Daily Volume | 0 |
VPHM
VS S&P 500 (SPY)
How do you think VPHM will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
VPHM Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
VPHM News and Commentary
- Update on VPHM's Industrial Facility - Analyst Blog – NASDAQ
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- The Fastest Growers in Pharma – The Motley Fool
- Is ViroPharma's Growth for Real? – The Motley Fool
- Priority Review for VPHM's Drug - Analyst Blog – NASDAQ
- Optimer Buoyant on Difficid Sales - Analyst Blog – NASDAQ
- Company News for January 9, 2012 - Corporate Summary – NASDAQ
- ViroPharma Expects a Strong 2012 - Analyst Blog – NASDAQ
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Too Early for a New Biotech Orphan? – The Motley Fool
- 3 Stocks Near 52-Week Highs Worth Selling – The Motley Fool
- Whoa! My Stock Just Whupped the Market! – The Motley Fool
- ViroPharma's Seizure Drug Reaches UK - Analyst Blog – NASDAQ
- ViroPharma-Halozyme Drug Advances - Analyst Blog – NASDAQ
- Optimer Moved Down to Neutral - Analyst Blog – NASDAQ
- Don't Get Too Worked Up Over ViroPharma's Latest Numbers – The Motley Fool
- Is ViroPharma's Growth for Real? – The Motley Fool
- ViroPharma Earnings Preview – The Motley Fool
- Is Optimer Pharmaceuticals the Perfect Stock? – The Motley Fool
RSS Headlines
Fool UK
